<div></div><div>[2] Forbes A, Kalantzis T. Crohn’s disease: the cold chain
hypothesis. Int J Colorectal Dis 2006;21:399–401.
doi:10.1007/s00384-005-0003-7.</div><div>[3] Shimane Y, Hatada Y, Minegishi H, Mizuki T, Echigo A, Miyazaki
M, et al. Natronoarchaeum mannanilyticum gen. nov., sp. nov., an
aerobic, extremely halophilic archaeon isolated from commercial salt.
Int J Syst Evol Microbiol 2010;60:2529–34. doi:10.1099/ijs.0.016600-0.</div><div>[4] Potgieter M, Bester J, Kell DB, Pretorius E. The dormant blood
microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev
2015;39:567–91. doi:10.1093/femsre/fuv013.</div><div>[5] Huffnagle GB, Dickson RP. The Bacterial Microbiota in
Inflammatory Lung Diseases. Clin Immunol 2015;159:177.
doi:10.1016/j.clim.2015.05.022.</div><div>[6] Branton WG, Ellestad KK, Maingat F, Wheatley BM, Rud E, Warren
RL, et al. Brain Microbial Populations in HIV/AIDS: α-Proteobacteria
Predominate Independent of Host Immune Status. PLoS One 2013;8:e54673.
doi:10.1371/journal.pone.0054673.</div><div>[7] Lagier J-C, Armougom F, Million M, Hugon P, Pagnier I, Robert C,
et al. Microbial culturomics: paradigm shift in the human gut microbiome
study. Clin Microbiol Infect 2012;18:1185–93.
doi:10.1111/1469-0691.12023.</div><div>[8] Earl CS, An S, Ryan RP. The changing face of asthma and its
relation with microbes. Trends Microbiol 2015;23:408–18.
doi:10.1016/j.tim.2015.03.005.</div><div>[9] Palm NW, Rosenstein RK, Medzhitov R. Allergic Host Defenses.
Nature 2012;484:465–72. doi:10.1038/nature11047.</div><div>[10] Sherman PW, Holland E, Sherman JS. Allergies: their role in
cancer prevention. Q Rev Biol 2008;83:339–62. doi:10.1086/592850.</div><div>[11] Manalai P, Hamilton RG, Langenberg P, Kosisky SE, Lapidus M,
Sleemi A, et al. Pollen-specific immunoglobulin E positivity is
associated with worsening of depression scores in bipolar disorder
patients during high pollen season. Bipolar Disord 2012;14:90–8.
doi:10.1111/j.1399-5618.2012.00983.x.</div><div>[12] Kelly K, Ratliff S, Mezuk B. Allergies, asthma, and
psychopathology in a nationally-representative US sample. J Affect
Disord 2019;251:130–5. doi:10.1016/j.jad.2019.03.026.</div><div>[13] Bluth MH, Robin J, Ruditsky M, Norowitz KB, Chice S, Pytlak E,
et al. IgE Anti-Borrelia burgdorferi Components (p18, p31, p34, p41,
p45, p60) and Increased Blood CD8 <sup>+</sup> CD60<sup>+</sup> T Cells in Children with Lyme Disease. Scand J
Immunol 2007;65:376–82. doi:10.1111/j.1365-3083.2007.01904.x.</div><div>[14] Li H, Zhou X-Y, Yang X-R, Zhu Y-G, Hong Y-W, Su J-Q. Spatial
and seasonal variation of the airborne microbiome in a rapidly
developing city of China. Sci Total Environ 2019;665:61–8.
doi:10.1016/j.scitotenv.2019.01.367.</div><div>[15] Qin T, Zhang F, Zhou H, Ren H, Du Y, Liang S, et al. High-Level
PM2.5/PM10 Exposure Is Associated With Alterations in the Human
Pharyngeal Microbiota Composition. Front Microbiol 2019;10:54.
doi:10.3389/fmicb.2019.00054.</div><div>[16] Croft DP, Zhang W, Lin S, Thurston SW, Hopke PK, Masiol M, et
al. The Association between Respiratory Infection and Air Pollution in
the Setting of Air Quality Policy and Economic Change. Ann Am Thorac Soc
2019;16:321–30. doi:10.1513/AnnalsATS.201810-691OC.</div><div>[17] Samek L. Overall human mortality and morbidity due to exposure
to air pollution. Int J Occup Med Environ Health 2016;29:417–26.
doi:10.13075/ijomeh.1896.00560.</div><div>[18] Horve PF, Lloyd S, Mhuireach GA, Dietz L, Fretz M, MacCrone G,
et al. Building upon current knowledge and techniques of indoor
microbiology to construct the next era of theory into microorganisms,
health, and the built environment. J Expo Sci Env Epidemiol
2019;30:219–35. doi:10.1038/s41370-019-0157-y.</div><div>[19] Gilbert JA, Stephens B. Microbiology of the built environment.
Nat Rev Microbiol 2018;16:661–670. doi:10.1038/s41579-018-0065-5.</div><div>[20] Jiang C, Wang X, Li X, Inlora J, Wang T, Liu Q, et al. Dynamic
Human Environmental Exposome Revealed by Longitudinal Personal
Monitoring. Cell 2018;175:277-291.e31. doi:10.1016/j.cell.2018.08.060.</div><div>[21] Trost B, Lucchese G, Stufano A, Bickis M, Kusalik A, Kanduc D.
No human protein is exempt from bacterial motifs, not even one. Self
Nonself 2010;1:328–34. doi:10.4161/self.1.4.13315.</div><div>[22] Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango MG,
Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on
Cross-Reactivity against Candida albicans. Cell 2019;176:1340-1355.e15.
doi:10.1016/j.cell.2019.01.041.</div><div>[23] Petersen J, Ciacchi L, Tran MT, Loh KL, Kooy-Winkelaar Y, Croft
NP, et al. T cell receptor cross-reactivity between gliadin and
bacterial peptides in celiac disease. Nat Struct Mol Biol
2020;27:49–61. doi:10.1038/s41594-019-0353-4.</div><div>[24] Scales BS, Dickson RP, LiPuma JJ, Huffnagle GB. Microbiology,
Genomics, and Clinical Significance of the Pseudomonas fluorescens
Species Complex, an Unappreciated Colonizer of Humans. Clin Microbiol
Rev 2014;27:927–48. doi:10.1128/CMR.00044-14.</div><div>[25] Waterhouse J. Exploring the microbiome’s potential role in
severe COVID-19: possible implications for prevention and treatment.
Authorea Prepr 2020. doi:10.22541/au.158758665.58622495.</div><div>[26] Del Poeta M, Casadevall A. Ten Challenges on Cryptococcus and
Cryptococcosis. Mycopathologia 2012;173:303–10.
doi:10.1007/s11046-011-9473-z.</div><div>[27] Casadevall A, Pirofski L. Benefits and Costs of Animal
Virulence for Microbes. MBio 2019;10:e00863-19.
doi:10.1128/mBio.00863-19.</div>